Saxagliptin And Metformin Tablet, Film Coated, Extended Release
Product Images NDC 0378-8177

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Saxagliptin And Metformin (NDC 0378-8177). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mylan Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Saxagliptin Hydrochloride Structural Formula (Image 01)

Chemical structure of the active ingredient saxagliptin, including its hydrochloride and dihydrate forms, illustrating its molecular components with labeled functional groups such as hydroxyl, amino, carbonyl, cyano, and the bicyclic ring system.*

FDA Label Image

Metformin Hydrochloride Structural Formula (Image 02)

Chemical structure of saxagliptin, one of the active ingredients in Saxagliptin and Metformin tablets.*

FDA Label Image

Figure 1: Mean Change From Baseline In A1c In A Placebo-controlled Trial Of Saxagliptin As Add-on Combination Therapy With Metformin Immediate-release* (Image 03)

A line graph depicting the mean percent change from baseline in A1C levels over 24 weeks for three treatment groups: Saxagliptin 2.5 mg plus Metformin, Saxagliptin 5 mg plus Metformin, and Placebo plus Metformin. The graph shows A1C changes at multiple time points (baseline, weeks 4, 6, 8, 12, 16, 20, and 24) with separate markers and lines for each group, illustrating differences in efficacy over time. Error bars are shown at week 24.*

FDA Label Image

Figure 2: Cumulative Percent Of Time To First Mace (Image 04)

Kaplan-Meier cumulative event probability plot showing time in days from randomization on the x-axis versus event probability on the y-axis. Two groups are represented: Saxagliptin (S) and Placebo (P), with similar event probabilities over approximately 1080 days. A legend with hazard ratio and confidence interval is included, along with a risk table below the graph reflecting patient counts over time.*

FDA Label Image

Saxagliptin And Metformin HCl Extended-release Tablets 5 mg/500 mg Bottle Label (Image 05)

Saxagliptin and Metformin HCl Extended-Release Tablets 5 mg/500 mg packaging label by Mylan Pharmaceuticals Inc. The label includes dosage form information (film-coated, extended-release tablets), quantity (30 tablets), pharmacist dispensing instructions, storage conditions, and a barcode with NDC 0378-8175-93. The label also highlights usage directions and a colored varnish-free area for lot, expiration, serial, and GTIN coding.*

FDA Label Image

Saxagliptin And Metformin HCl Extended-release Tablets 5 mg/1000 mg Bottle Label (Image 06)

Saxagliptin and Metformin HCl Extended-Release Tablets 5 mg/1000 mg by Mylan Pharmaceuticals Inc. The film-coated tablets are for oral use, packaged in a 30-tablet container. The label includes dosing information, storage instructions, a barcode, and manufacturer details, emphasizing the tablets must be swallowed whole and dispensed with accompanying medication guides.*

FDA Label Image

Saxagliptin And Metformin HCl Extended-release Tablets 2.5 mg/1000 mg Bottle Label (Image 07)

Saxagliptin and Metformin HCl Extended-Release Tablets label showing 2.5 mg saxagliptin and 1000 mg metformin strength. The film-coated tablets are packaged by Mylan Pharmaceuticals Inc. The label includes dosing information, storage instructions, and a barcode with NDC 0378-8176-93. The package contains 30 tablets. Additional printing sections for lot number, expiration date, and serial number are also shown.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.